A detailed history of Peak6 Investments LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Peak6 Investments LLC holds 8,000 shares of VRTX stock, worth $3.27 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8,000
Previous 7,900 1.27%
Holding current value
$3.27 Million
Previous $3.7 Million 0.49%
% of portfolio
0.01%
Previous 0.01%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$460.0 - $505.78 $37,720 - $41,473
82 Added 8200.0%
83 $38,000
Q2 2024

Aug 13, 2024

SELL
$392.81 - $485.53 $392 - $485
-1 Reduced 50.0%
1 $0
Q4 2023

Feb 13, 2024

SELL
$343.0 - $410.68 $907,921 - $1.09 Million
-2,647 Reduced 99.92%
2 $0
Q3 2023

Nov 13, 2023

BUY
$338.18 - $362.46 $746,025 - $799,586
2,206 Added 497.97%
2,649 $921,000
Q2 2023

Aug 11, 2023

BUY
$314.42 - $351.91 $139,288 - $155,896
443 New
443 $155,000
Q4 2022

Feb 10, 2023

BUY
$285.76 - $321.48 $317,479 - $357,164
1,111 Added 76.46%
2,564 $741,000
Q3 2022

Nov 14, 2022

BUY
$273.83 - $305.53 $397,327 - $443,324
1,451 Added 72550.0%
1,453 $421,000
Q2 2022

Aug 12, 2022

SELL
$234.96 - $292.55 $2.48 Million - $3.09 Million
-10,559 Reduced 99.98%
2 $1,000
Q1 2022

May 13, 2022

SELL
$221.42 - $260.97 $277,660 - $327,256
-1,254 Reduced 10.61%
10,561 $2.76 Million
Q4 2021

Feb 11, 2022

SELL
$177.01 - $223.45 $4.14 Million - $5.22 Million
-23,374 Reduced 66.42%
11,815 $2.6 Million
Q3 2021

Nov 12, 2021

BUY
$181.39 - $202.99 $6.38 Million - $7.14 Million
35,183 Added 586383.31%
35,189 $6.38 Million
Q2 2021

Aug 13, 2021

SELL
$187.49 - $221.1 $3.39 Million - $4 Million
-18,104 Reduced 99.97%
6 $1,000
Q1 2021

May 14, 2021

SELL
$207.02 - $241.31 $7.09 Million - $8.26 Million
-34,234 Reduced 65.4%
18,110 $3.89 Million
Q4 2020

Feb 12, 2021

BUY
$207.01 - $276.09 $10 Million - $13.4 Million
48,508 Added 1264.55%
52,344 $12.4 Million
Q3 2020

Nov 13, 2020

SELL
$255.65 - $303.1 $912,670 - $1.08 Million
-3,570 Reduced 48.2%
3,836 $1.04 Million
Q4 2019

Feb 13, 2020

SELL
$166.71 - $223.91 $5.99 Million - $8.04 Million
-35,915 Reduced 82.9%
7,406 $1.62 Million
Q3 2019

Nov 08, 2019

BUY
$166.23 - $187.09 $5.26 Million - $5.92 Million
31,640 Added 270.87%
43,321 $7.34 Million
Q1 2019

May 15, 2019

BUY
$163.73 - $194.7 $1.91 Million - $2.27 Million
11,681 New
11,681 $2.15 Million

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Peak6 Investments LLC Portfolio

Follow Peak6 Investments LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Peak6 Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Peak6 Investments LLC with notifications on news.